← Eichor
Study identifier: NCT06747130 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients

Condition: Dengue · Montelukast · Transaminases  ·  Sponsor: Phramongkutklao College of Medicine and Hospital

PhasePhase 2/Phase 3
Planned participants82
Who can joinAll sexes, 20 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn if drug montelukast works to treat dengue in adults. It will also learn about the safety of drug montelukast . The main questions it aims to answer are: Does drug montelukast lower the incidence of liver enzyme elevations in participants ? What medical problems do participants have when taking drug montelukast ?

This description comes directly from the study's public registry record.

Talk to the study team

Vasin Vasikasin, MD PhD  ·  66+027639300  ·  vvasin@gmail.com

Kotchaphon Waithayakul, MD  ·  66+027639300  ·  nasomsong.w@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Phramongkutklao HospitalBangkok, ThailandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06747130